Titre:
  • Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.
Auteur:Gómez-Aleza, Clara; Nguyen, Bastien; Yoldi, Guillermo; Ciscar, Marina; Barranco, Alexandra; Hernández-Jiménez, Enrique; Maetens, Marion; Salgado, Roberto; Zafeiroglou, Maria; Pellegrini, Pasquale; Venet, David; Garaud, Soizic; Trinidad, Eva Ma; Benítez, Sandra; Vuylsteke, Peter; Polastro, Laura; Wildiers, Hans; Simon, Philippe; Lindeman, Geoffrey G.J.; Larsimont, Denis; Van den Eynden, Gert; Velghe, Chloé; Rothé, Françoise; Willard-Gallo, Karen; Michiels, Stefan; Muñoz, Purificación; Walzer, Thierry; Planelles, Lourdes; Penninger, Josef; Azim, Hatem A; Loi, Sherene; Piccart, Martine; Sotiriou, Christos; González-Suárez, Eva
Informations sur la publication:Nature communications, 11, 1, page (6335)
Statut de publication:Publié, 2020-01-01
Sujet CREF:Cancérologie
Sciences bio-médicales et agricoles
Médecine pathologie humaine
MeSH keywords:Adult
Animals
Breast Neoplasms -- blood -- drug therapy -- immunology -- pathology
CD8-Positive T-Lymphocytes -- immunology
Cell Line, Tumor
Chemokines -- metabolism
Denosumab -- pharmacology -- therapeutic use
Female
Humans
Immunity
Immunosuppression
Immunotherapy
Inflammation Mediators -- metabolism
Lymphocytes, Tumor-Infiltrating -- immunology
Mice, Inbred C57BL
Middle Aged
Models, Biological
Myeloid Cells -- immunology
Neoplasm Staging
Neutrophils -- immunology
RANK Ligand -- blood -- metabolism
Receptor Activator of Nuclear Factor-kappa B -- metabolism
Signal Transduction
Langue:Anglais
Identificateurs:urn:issn:2041-1723
info:doi/10.1038/s41467-020-20138-8
info:pii/10.1038/s41467-020-20138-8
info:pmid/33303745
PMC7728758